Annual report pursuant to Section 13 and 15(d)

SEGMENT INFORMATION (Tables)

v3.20.4
SEGMENT INFORMATION (Tables)
12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Schedule Of Segment Reporting Information
The following table presents information by reportable operating segment for the years ended December 31, 2020 and 2019 (in thousands):
Consumer Products
Segment
Specialty Pharmaceutical Segment Consolidated Totals
Year ended December 31, 2020:      
Product sales, net $ 24,429  $ —  $ 24,429 
Gross profit $ 11,009  $ —  $ 11,009 
Research and development 678  2,265  2,943 
Selling, general and administrative 30,547  111  30,658 
Operating loss $ (20,216) $ (2,376) $ (22,592)
Year ended December 31, 2019:
Product sales, net $ 53,696  $ —  $ 53,696 
Gross profit $ 35,088  $ —  $ 35,088 
Research and development 2,106  3,771  5,877 
Selling, general and administrative 46,405  46  46,451 
Operating loss $ (13,423) $ (3,817) $ (17,240)